 |
Prof. Andrew Rees Professorial Fellow, Clinical Department of Pathology, Medical University of Vienna, Austria Phone: +43(1) 40400-3681 Fax: +43(1) 40400-5193  Contact |
Andy Rees holds a Professorial Fellowship at the Clinical Institute of Pathology, Medical University of Vienna. He qualified in Medicine in Liverpool and trained in internal medicine and nephrophrology in London first with Stewart Cameron at Guys Hospital and then with Keith Peters at Royal Postgraduate Medical School. He became a Senior Lecturer at RPMS and subsequently Professor of Nephrology and head of the unit. In 2004, he was appointed Regius Professor in Medicine at Aberdeen University. He moved to Vienna in 2007. Throughout his career, Professor Rees' research has focussed on the clinical and pathogenetic aspects of glomerulonephritis - especially the various types of focal necrotizing glomerulonephritis. His current work concentrates on autoimmunity to glomerular proteins in pauci-immune FNGN and the role of differential macrophage activation in executing the injury it causes. He is a Fellow of the Academy of Medical Sciences and the Society of Biologists in the UK. He chairs the European Vasculitis Genetics Consortium and the European Kidney Health Alliance.
http://www.ncbi.nlm.nih.gov/pubmed?term=%22Rees%20AJ%22%5BAuthor%5DThe Medical University of Vienna is the largest medical research institution in Austria. It was founded in 1365 as a Medical Faculty of the University of Vienna and has operated as an independent institution in the scope of autonomous university and self administration since 2004.
The Clinical Institute of Pathology in the Medical University of Vienna is one of the foremost Pathology research institutes in the world. Located in the General Hospital, the Institute's clinical workload exceeds 35000 histological requests and provides clinical services to the community of Vienna at the forefront of diagnostic methodology including conventional histology, immunohistochemistry and electron microscopy but also develops novel approaches such as molecular analysis and cytogenetics.
Consortium
About TranSVIR
